Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$28K
-40.5% from 2023
Prescriptions
59
$468.69 per claim
Patients
-
4 prescribers
Total spending, 2024
$27K
- per patient
Medicare prescription drug plans paid $28K for Rifadin in 2024, for 59 prescriptions and refills to - patients (down 40.5% from 2023). The average cost per claim was $468.69.
Illinois had the highest Medicare cost for Rifadin in 2024: $19K for 51 claims.
John Bolden Jr., infectious disease in Morris, IL, had the highest Medicare cost for Rifadin in 2024: 51 claims costing $19K.
Rifadin is made by Sanofi (SNY), listed in the Medicare spending data as Sanofi-Aventis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| John Bolden Jr. Morris, IL | Infectious Disease | 51 | Under 11 | $19K |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 11 | 152 | - | $61K |
| 2023 | 6 | 105 | - | $46K |
| 2024 | 4 | 59 | - | $28K |
Spending by manufacturer as listed in the spending data
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Manufacturer | Claims | Spending |
|---|---|---|
| Sanofi-Aventis SNY | 58 | $27K |